DK0904282T3 - Hidtil ukendte kationiske cholesterylderivater indeholdende cykliske polære grupper - Google Patents

Hidtil ukendte kationiske cholesterylderivater indeholdende cykliske polære grupper

Info

Publication number
DK0904282T3
DK0904282T3 DK97920357T DK97920357T DK0904282T3 DK 0904282 T3 DK0904282 T3 DK 0904282T3 DK 97920357 T DK97920357 T DK 97920357T DK 97920357 T DK97920357 T DK 97920357T DK 0904282 T3 DK0904282 T3 DK 0904282T3
Authority
DK
Denmark
Prior art keywords
polar groups
containing cyclic
derivatives containing
novel cationic
cholesteryl derivatives
Prior art date
Application number
DK97920357T
Other languages
Danish (da)
English (en)
Inventor
Hemant M Deshmukh
Leaf Huang
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Application granted granted Critical
Publication of DK0904282T3 publication Critical patent/DK0904282T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97920357T 1996-04-12 1997-04-11 Hidtil ukendte kationiske cholesterylderivater indeholdende cykliske polære grupper DK0904282T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63120396A 1996-04-12 1996-04-12
PCT/US1997/006066 WO1997039019A1 (en) 1996-04-12 1997-04-11 Novel cationic cholesteryl derivatives containing cyclic polar groups

Publications (1)

Publication Number Publication Date
DK0904282T3 true DK0904282T3 (da) 2002-03-04

Family

ID=24530212

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97920357T DK0904282T3 (da) 1996-04-12 1997-04-11 Hidtil ukendte kationiske cholesterylderivater indeholdende cykliske polære grupper

Country Status (8)

Country Link
US (1) US6927213B2 (de)
EP (1) EP0904282B1 (de)
AT (1) ATE210145T1 (de)
CA (1) CA2251543A1 (de)
DE (1) DE69708868T2 (de)
DK (1) DK0904282T3 (de)
ES (1) ES2165050T3 (de)
WO (1) WO1997039019A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6120794A (en) 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells
CA2259179C (en) 1996-07-03 2008-09-23 University Of Pittsburgh Emulsion formulations for hydrophilic active agents
US5925628A (en) * 1997-03-31 1999-07-20 Genzyme Corporation Cationic amphiphiles for intracellular delivery of therapeutic molecules
US5912239A (en) * 1997-04-04 1999-06-15 Genzyme Corporation Imidazole-containing cationic amphiphiles for intracellular delivery of therapeutic molecules
US5948925A (en) * 1997-05-06 1999-09-07 Genzyme Corporation Cationic amphiphiles containing linkers derived from neutral or positively charged amino acids
US5952516A (en) * 1997-05-08 1999-09-14 Genzyme Corporation Cationic amphiphiles containing multiplesteroid lipophilic groups
US5942634A (en) * 1997-05-09 1999-08-24 Genzyme Corporation Cationic amphiphiles for cell transfections
GB0015624D0 (en) * 2000-06-26 2000-08-16 Nat Cancer Centre Materials and methods relating to improved gene delivery
GB2372502B (en) * 2000-12-12 2004-10-13 Imperial College Carbohydrate compounds containing cholesterol and their use
DE10109897A1 (de) 2001-02-21 2002-11-07 Novosom Ag Fakultativ kationische Liposomen und Verwendung dieser
DE10109898A1 (de) * 2001-02-21 2002-09-05 Novosom Gmbh Lipide mit veränderlicher Ladung
US7858117B2 (en) 2002-02-21 2010-12-28 Novosom Ag Amphoteric liposomes and their use
CA2724408A1 (en) * 2008-05-19 2009-11-26 The University Of North Carolina At Chapel Hill Methods and compositions comprising novel cationic lipids
CN111902397B (zh) 2018-03-27 2024-04-12 日油株式会社 改进了细胞内动力学的阳离子脂质

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE589491A (de) * 1959-04-10
US3459766A (en) 1965-03-12 1969-08-05 Du Pont 2,2,5,5-tetrakis(polyfluoromethyl)imidazolidines and their preparation
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4958013A (en) 1989-06-06 1990-09-18 Northwestern University Cholesteryl modified oligonucleotides
US5100662A (en) 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
US5676954A (en) 1989-11-03 1997-10-14 Vanderbilt University Method of in vivo delivery of functioning foreign genes
WO1993003709A1 (en) 1991-08-16 1993-03-04 Vical, Inc. Composition and method for treating cystic fibrosis
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
JP2990624B2 (ja) * 1991-10-21 1999-12-13 味の素株式会社 油溶性ｎ−長鎖アシル中性アミノ酸エステル及びそれらを含む香粧品及び外用医薬基剤
US5756353A (en) 1991-12-17 1998-05-26 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol-and liposome-based delivery
EP0646178A1 (de) 1992-06-04 1995-04-05 The Regents Of The University Of California Expression kassette mit im säugetier wirt funktionnellen regulator sequenzen
US5646126A (en) 1994-02-28 1997-07-08 Epoch Pharmaceuticals Sterol modified oligonucleotide duplexes having anticancer activity
JP4285766B2 (ja) 1994-03-23 2009-06-24 オハイオ ユニバーシティ 緻密にした核酸および細胞へのデリバリ
US6077835A (en) 1994-03-23 2000-06-20 Case Western Reserve University Delivery of compacted nucleic acid to cells
US6071890A (en) * 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
US5635487A (en) 1994-12-29 1997-06-03 Wolff; Jon A. Amphipathic, micellar delivery systems for biologically active polyions
US5795587A (en) 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US6008202A (en) 1995-01-23 1999-12-28 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
GB9515356D0 (en) 1995-07-26 1995-09-20 Medical Res Council Improvements in or relating to delivery of nucleic acid
AU6691496A (en) * 1995-08-01 1997-02-26 Advanced Therapies, Inc. Enhanced artificial viral envelopes for cellular delivery of therapeutic substances
US6120794A (en) 1995-09-26 2000-09-19 University Of Pittsburgh Emulsion and micellar formulations for the delivery of biologically active substances to cells
CA2259179C (en) 1996-07-03 2008-09-23 University Of Pittsburgh Emulsion formulations for hydrophilic active agents
DK0941066T3 (da) 1996-08-26 2004-02-23 Transgene Sa Kationisk lipid-nukleinsyre-komplekser
US6271209B1 (en) 1998-04-03 2001-08-07 Valentis, Inc. Cationic lipid formulation delivering nucleic acid to peritoneal tumors

Also Published As

Publication number Publication date
EP0904282A1 (de) 1999-03-31
DE69708868D1 (de) 2002-01-17
US20030203871A1 (en) 2003-10-30
EP0904282B1 (de) 2001-12-05
ATE210145T1 (de) 2001-12-15
US6927213B2 (en) 2005-08-09
DE69708868T2 (de) 2002-07-18
AU715376B2 (en) 2000-02-03
ES2165050T3 (es) 2002-03-01
WO1997039019A1 (en) 1997-10-23
AU2457397A (en) 1997-11-07
CA2251543A1 (en) 1997-10-23

Similar Documents

Publication Publication Date Title
DK0904282T3 (da) Hidtil ukendte kationiske cholesterylderivater indeholdende cykliske polære grupper
DE69710104D1 (de) Bindemittellösung auf Vinylidenfluorid-Basis und Zusammensetzung zur Herstellung von Elektroden
ES2192224T3 (es) Isotiazolonas.
IL143670A0 (en) Methods for the expression of active protein-immunoglobulin fusions, active protein-immunoglobulin fusions obtained thereby and pharmaceutical compositions containing the same
DE69530183D1 (de) Herstellung von plasmid dns von pharmazeutischer güte
BG103251A (bg) Оксадиазоли, методи за получаването им и приложението им като лекарствени средства
DE69831589D1 (de) Zusammenfügung von knorpelmatrizen unter verwendung isolierter chondrozyten
CU23048A3 (es) Aminoacidos ciclicos y derivados de los mismos, utiles como agentes farmaceuticos
DE3689572D1 (de) Verfahren zur Isolierung von Genen zur Biosynthese von Antibiotika.
DE68925083D1 (de) Rekombinante DNS, diese rekombinante DNS enthaltender Mikroorganismus und Verfahren zur Herstellung von L-Aminosäure unter Verwendung dieses Mikroorganismus
DK0409472T3 (da) Knoglemorfogenetisk protein
FI961809A0 (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
FR2603037B1 (fr) (pentamethyl-1,2,2,6,6,6 piperidyl-4 amino)- triazines, leur application comme stabilisants de matieres organiques, et compositions qui en contiennent
EP1015470A4 (de) Zusammensetzung und herstellung zum fordern von nukleinsauren
UA26431A (uk) Похідhі сиh-ізомеру цефалоспориhу, їх оптичhо активhі аhтиподи або рацемічhа суміш, а також їх фармацевтичhо прийhятhі кислотhо-адитивhі солі
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
LTIP610A (en) Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds
DE3683425D1 (de) Polyesterkarbonat des imidgruppierungen enthaelt, und verfahren fuer dessen herstellung.
FR2567884B1 (fr) Nouveaux derives de l'indole, leur preparation, leur application comme medicaments et les compositions les renfermant
ATE246935T1 (de) Zns neuroregenerative zusammensetzungen und deren verwendungen
WO1990007321A3 (en) Lymphocyte receptor homing sequences and their uses
DK93886A (da) Molekylaer kloning af delta-endotoksingenet af bacillus thuringiensisvar. israelensis
UA15920A (uk) Аміди циклометілеh-1, 2-дикарбоhових кислот, які мають гіпотеhзивhу активhість
DE3783145D1 (de) Rekombinantes dns-plasmid zur herstellung von xanthangummi.
DE3688397D1 (de) 3-(2-aminoethyl)indol und -indolinderivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.